ALEXIA GRANT D.

ANTEROLA
3BSN

DRUG STUDY
PATIENT X;
DOA: NOV 16, 2018;
ADMITTING DIAGNOSIS: ELECTROLYTE IMBALANCE (HYPOKALEMIA);
ATTENDING PHYSICIAN: DR. SONNY F. ABSALON

MEDICATION / MECHANISM OF INDICATION CONTRAINDICATION ADVERSE EFFECTS NRSG RESP.

ROUTE / DOSE ACTION
Metoclopramide  Dopamine  For the  Metoclopramide  Depression  Inject IV
antagonist treatment of should not be (with slowly
Classification: that acts by gastro- used whenever suicidal over 1-2
Gastrointestinal increasing esophageal stimulation of ideation), mins to
stimulant sensitivity to reflux disease gastrointestinal seizures, prevent
acetylcholine; (GERD) motility might be hypotension transient
 TIV results dangerous, e.g., feelings
 10mg/amp increase in the presence of
 Q8 PRN motility of of anxiety
the upper GI gastrointestinal  Note
tract and hemorrhage, reasons
relaxation of mechanical for
pyloric obstruction, or therapy
sphincter and perforation.  Assess
duodenal  Metoclopramide abdomin
bulb is contra- al bowel
indicated in sounds,
patients with distentio
pheochro- n, and
mocytoma n/v
because the
ALEXIA GRANT D. ANTEROLA
3BSN

drug may cause

a hypertensive
crisis, probably
due to release of
catecholamines
from the tumor.
Such
hypertensive
crises may be
controlled by
phentolamine
 Metoclopramide
should not be
used in epileptics
or patients
receiving other
drugs which are
likely to cause
extrapyramidal
reactions, since
the frequency
and severity of
seizures
orextrapyramida
l reactions may
be increased.
Omeprazole  Gastric acid- Indicated for:  Contraindicat  CNS:  Give
pump ed with : Headache, medicati
Classification: inhibitor:  Short-term hypersensitivi dizziness, asthenia, on
Proton Pump Suppresses treatment ty to vertigo, insomnia, before
Inhibitor gastric acid of active omeprazole apathy, anxiety, meals,
ALEXIA GRANT D. ANTEROLA
3BSN

secretion by duodenal or its paresthesias, preferab

 IV specific ulcer; First- components; dream ly in the
 40mg inhibition of line therapy Use cautiously abnormalities morning
 OD the in treatment with  DERMATOL for
hydrogen- of heartburn pregnancy, OGIC once-
potassium or symptoms lactation : Rash, daily
ATPase of gastroesop inflammation, dosing.
enzyme hageal reflux urticaria, pruritus, If
system at the disease alopecia, dry skin necessar
secretory (GERD);  GI: y, also
surface of the : Diarrhea, give an
gastric  Short-term abdominal pain, antacid,
parietal cells; treatment nausea, vomiting, as
blocks the of active constipation, dry prescrib
final step of benign gastric mouth, tongue ed.
acid ulcer; atrophy
production  RESPIRATOR
  GERD, severe Y  Encoura
erosive : URI symptoms, ge
esophagitis, cough, epistaxis patient
poorly  OTHERS to avoid
responsive : Cancer in alcohol,
symptomatic preclinical studies, aspirin
GERD; back pain, fever products
,
 Long-term ibuprofe
therapy: n, and
Treatment of foods
pathologic that may
hypersecreto increase
ry conditions gastric
ALEXIA GRANT D. ANTEROLA
3BSN

(Zollinger- secretio
Ellisonsyndro ns
me, multiple during
adenomas, therapy.
systemic
mastocytosis)
;

Eradication of H.
pylori with
amoxicillin
ormetronidazole and
clarithromycin

Potassium Chloride  Maintain  Treatment/pr  Contraindicated  CNS:  Assess

acid-base evention of in hyperkalemia; confusion, for s/s of
Classification: balance, potassium severer renal restlessness hypokal
Mineral and isotonicity, depletion impairment; , weakness emia
electrolyte andelec- untreated  CV:  Monitor
supplement trophysiologi Addison’s Arrhythmias for U
c balance of disease; severe , ECG wave in
 PO the cell. tissue trauma; changes ECG
 600mg/tab Activator in hyperkalemic  GI:  Monitor
 2 tabs Q8 many familial periodic Abdominal serum
enzymatic paralysis pain, potassiu
reactions; diarrhea, m
essential to flatulence, before
transmission vomiting, GI and
of nerve ulceration, periodic
impulses; ally
ALEXIA GRANT D. ANTEROLA
3BSN

contraction stenotic during

of cardiac, lesions therapy
skeletal, and  NEURO:
smooth paralysis,
muscle; paresthesia
gastric
secretion;
renal
function;
tissue
synthesis;
and
carbohydrate
metabolism.
 Therapeutic
Effects:
Replacement.
Prevention of
deficiency.